Paper Details
- Home
- Paper Details
Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study.
Author: ArgyriIoanna, CoffinSusan E, MaritsiDespoina N, SpyridisNick, TsoliaMaria N, VartzelisGeorge
Original Abstract of the Article :
OBJECTIVES: To describe the immunogenicity and side effects of immunisation against hepatitis A virus (HAV) in JIA patients on methotrexate treatment, who have not been previously exposed to HAV. METHODS: Case-control study performed in JIA patients and healthy controls matched on age and gender. T...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/28721859
データ提供:米国国立医学図書館(NLM)
Hepatitis A Vaccine Safety and Immunogenicity in Children with Juvenile Idiopathic Arthritis
The field of [vaccine efficacy] is constantly evolving, with researchers seeking to ensure that vaccines are safe and effective for diverse populations. This study investigates the [immunogenicity and safety] of the [inactivated hepatitis A vaccine] in [children with juvenile idiopathic arthritis (JIA)] who are undergoing [methotrexate treatment]. The researchers aim to determine the vaccine’s effectiveness in inducing protective immunity and assess its safety profile in this specific patient group.
Vaccine Efficacy in Children with JIA
The study found that the inactivated hepatitis A vaccine was well-tolerated and immunogenic in most children with JIA receiving methotrexate treatment. However, the study also revealed that a single dose of the vaccine was insufficient to induce seroprotection in half of the patients. This highlights the importance of administering the full recommended vaccine regimen to ensure optimal protection against hepatitis A in children with JIA. The authors recommend further research to analyze the long-term immunity against HAV in this population and determine the optimal immunization schedule.
Vaccination and Immune System Considerations
It’s essential to remember that children with JIA may have a weakened immune system due to their condition and medications. This can affect their response to vaccines. Talk to your doctor about the recommended vaccine schedule for your child, especially if they have JIA or are undergoing any immunosuppressive treatments. They can provide personalized guidance based on your child’s individual needs.
Dr. Camel’s Conclusion
This study provides valuable information about the safety and immunogenicity of the hepatitis A vaccine in children with JIA on methotrexate treatment. While the vaccine was generally effective and well-tolerated, the study highlights the importance of administering the full recommended vaccine regimen to ensure optimal protection. The authors’ call for further research is crucial in determining the optimal immunization schedule for this specific population. Remember, vaccination is a powerful tool for preventing disease, and it’s essential to follow the recommended guidelines to protect yourself and your loved ones.
Date :
- Date Completed 2017-08-31
- Date Revised 2017-08-31
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.